Novacyt S.A.

LSE • Healthcare • Medical Devices • Quote as of 10/27/2026 15:51

Company Profile

IndustryMedical Devices

SectorHealthcare

ExchangeLSE

Market Capitalization28.28 mln

Float72.44 mln

Earnings Date04/30/2027

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

-3.42

Reliable

Relative Strength

22 / 100

Significantly lagging

Debt / Equity

0.45

Low leverage

Pre-Tax Margin

-135%

Severely loss-making

ROE

-60.12

Deeply negative

Business Description

Novacyt S.A. is a French company founded in 2006 that develops and sells molecular testing products and services for human health, animal health, and environmental applications. Its two main divisions cover reproductive health and precision medicine diagnostics, as well as real-time PCR testing tools for infectious diseases. The company sells its products across the UK, France, the US, Asia Pacific, the Middle East, and Africa.

Key Fundamentals

EPS-31.00

ROE-60.12

RPS0.31

ROIC-36.88

ROA-38.80

Interest Cover-23.33

EBITDA, mln-21.86

EV / EBITDA-1.03

EV / EBIT-0.84

Revenue, mln20.03

EV / Revenue1.11

Quote Details

Last 37.44

Change -1.62 (-4.15%)

Open 38.10

Volume 59,937

Turnover 2,244,041

Average Volume 119,830

Financial Ratios

Pre-Tax Profit Margin-135

Leverage Ratio2.01

Current Ratio4.74

Price / Book1.25

Price / Tangible Book1.48

Debt / Equity0.45

Price / Sales1.43

Financial Strength

Altman Z-Score-1.8

Piotroski F-Score 4 / 9

Beneish M-Score-3.42

Price to Intrinsic Value0.33

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-4.73%	10 / 100
1 Month	-13.81%	6 / 100
2 Months	-1.47%	43 / 100
6 Months	13.8%	82 / 100
1 Year	-6.4%	23 / 100